Friday, August 9, 2024 episode artwork

EPISODE · Aug 9, 2024 · 9 MIN

Friday, August 9, 2024

from The Gist Healthcare Podcast

CMS finalizes a policy that creates a faster pathway to reimbursement for “breakthrough” medical devices. The FDA approves Purdue Pharma’s opioid overdose-reversal device. And a recent report finds that untreated vision loss and high cholesterol could be risk factors for dementia. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

CMS finalizes a policy that creates a faster pathway to reimbursement for “breakthrough” medical devices. The FDA approves Purdue Pharma’s opioid overdose-reversal device. And a recent report finds that untreated vision loss and high cholesterol could be risk factors for dementia. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

NOW PLAYING

Friday, August 9, 2024

0:00 9:12

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The Gist Healthcare Podcast?

This episode is 9 minutes long.

When was this The Gist Healthcare Podcast episode published?

This episode was published on August 9, 2024.

What is this episode about?

CMS finalizes a policy that creates a faster pathway to reimbursement for “breakthrough” medical devices. The FDA approves Purdue Pharma’s opioid overdose-reversal device. And a recent report finds that untreated vision loss and high cholesterol...

Can I download this The Gist Healthcare Podcast episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!